Compare PPCB & AQB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | PPCB | AQB |
|---|---|---|
| Founded | 2007 | 1991 |
| Country | Australia | United States |
| Employees | N/A | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2M | 3.3M |
| IPO Year | N/A | 2017 |
| Metric | PPCB | AQB |
|---|---|---|
| Price | $0.12 | $0.93 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 1.2M | 23.7K |
| Earning Date | 02-17-2026 | 04-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,472,659.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.11 | $0.54 |
| 52 Week High | $10.69 | $2.95 |
| Indicator | PPCB | AQB |
|---|---|---|
| Relative Strength Index (RSI) | 28.08 | 49.45 |
| Support Level | N/A | $0.87 |
| Resistance Level | $0.40 | $0.96 |
| Average True Range (ATR) | 0.02 | 0.07 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 7.02 | 46.71 |
Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.
AquaBounty Technologies Inc is engaged in the field of land-based aquaculture and the use of technology to improve the productivity and sustainability. The company's objective is to ensure the availability of high-quality seafood to meet consumer demand while addressing critical production constraints in the popular farmed species.